State NH
Clinical Trials in New Hampshire
New Hampshire is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Hampshire and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 56 actively recruiting studies with New Hampshire sites out of 56 registered in total. The busiest research areas in New Hampshire are Breast Cancer, Anatomic Stage IV Breast Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8. Leading sponsors running trials in the state include Dartmouth-Hitchcock Medical Center, SWOG Cancer Research Network, NRG Oncology. By stage, New Hampshire trials break down as Phase 1 (4), Phase 2 (16), Phase 3 (15), Phase 4 (1).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Hampshire
Breast Cancer (4)Anatomic Stage IV Breast Cancer AJCC v8 (2)Stage III Pancreatic Cancer AJCC v8 (2)Amyotrophic Lateral Sclerosis (2)Malignant Solid Neoplasm (2)Carcinoma, Non-Small-Cell Lung (2)Intracranial Meningioma (2)Acute Myeloid Leukemia (2)Lymphoma, Non-Hodgkin (1)Multiple Myeloma (1)Advanced Solid Tumors (1)Estrogen Receptor Positive (1)
Frequently Asked Questions — Clinical Trials in New Hampshire
How many clinical trials are currently recruiting in New Hampshire?
ClinicalMetric currently tracks 56 actively recruiting clinical trials with at least one location in New Hampshire. The total number of registered studies—including active but not currently enrolling trials—is 56. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Hampshire?
New Hampshire hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Anatomic Stage IV Breast Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Hampshire serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Hampshire?
To join a clinical trial in New Hampshire, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Hampshire maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Hampshire
NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT07533019 Phase 2
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Condition
Vitiligo
Enrollment
66 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
NCT05139277 N/A
Recruiting
Evaluation of the CONVIVO System
Condition
Glioblastoma
Enrollment
30 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06134375 Phase 1, Phase 2
Recruiting
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Condition
Triple Negative Breast Cancer
Enrollment
204 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT07226869 N/A
Recruiting
Computer Guided Microwave Liver Ablation
Condition
Hepatocellular Carcinoma (HCC)
Enrollment
84 pts
Location
United States
Sponsor
NE Scientific INC
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT05313165 N/A
Recruiting
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-St...
Condition
Critical Limb Ischemia
Enrollment
100 pts
Location
United States
Sponsor
LimFlow, Inc.
NCT06111781 Phase 2
Recruiting
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Condition
Prostate Cancer
Enrollment
60 pts
Location
United States
Sponsor
Yale University
NCT06218875 N/A
Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endopros...
Condition
AAA - Abdominal Aortic Aneurysm
Enrollment
2,000 pts
Location
United States, Australia, Austria
Sponsor
W.L.Gore & Associates
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT04907396 N/A
Recruiting
International Weight Control Registry
Condition
Weight Loss
Enrollment
100,000 pts
Location
United States
Sponsor
Tufts University
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT05899608 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
1,600 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
NCT04172532 Phase 1, Phase 2
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06491732 N/A
Recruiting
EIM Via the Myolex mScan as an ALS Biomarker
Condition
Amyotrophic Lateral Sclerosis
Enrollment
80 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
NCT04165798 N/A
Recruiting
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Eithe...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
1,065 pts
Location
United States, Hungary, Israel
Sponsor
Merck Sharp & Dohme LLC
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT07035925 N/A
Recruiting
Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of...
Condition
Fistula in Ano
Enrollment
10 pts
Location
United States
Sponsor
ECM Therapeutics, Inc.
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT03003299 N/A
Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
Condition
Aortic Stenosis
Enrollment
125 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT06616584 Phase 2, Phase 3
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Adva...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
378 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04071847 N/A
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Condition
Movement Disorders
Enrollment
1,000 pts
Location
United States, Australia, Finland
Sponsor
Abbott Medical Devices
Page 1 of 3 — 56 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology